ARK ETF TR - GENOMIC REV ETF (ARKG)

Historical Holders from Q4 2014 to Q3 2025

Symbol
ARKG
Type / Class
Equity / GENOMIC REV ETF
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,010,714
Holdings value
$611,574,253
% of all portfolios
0%
Number of holders
225
Number of buys
93
Number of sells
-81
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 22,010,714 $611,574,253 +$21,241,825 $27.77 225
2025 Q2 21,611,541 $526,299,881 -$30,340,417 $24.35 208
2025 Q1 23,101,944 $479,673,052 -$55,581,611 $20.76 208
2024 Q4 24,359,584 $573,766,398 -$37,881,926 $23.54 233
2024 Q3 27,319,167 $699,250,691 +$92,150,396 $25.6 236
2024 Q2 22,697,563 $533,360,015 +$39,104,434 $23.48 255
2024 Q1 21,070,311 $605,869,850 +$29,425,107 $28.76 278
2023 Q4 18,854,497 $618,680,538 +$12,657,699 $32.81 295
2023 Q3 15,272,259 $424,908,985 -$83,636,429 $27.86 280
2023 Q2 19,519,789 $665,172,681 -$81,152,901 $34.09 285
2023 Q1 22,230,141 $668,316,409 +$77,890,388 $30.07 287
2022 Q4 18,500,202 $522,559,625 -$45,769,022 $28.23 308
2022 Q3 21,745,645 $714,574,611 +$11,094,001 $32.87 290
2022 Q2 19,759,934 $624,634,834 -$149,931,968 $31.49 311
2022 Q1 23,308,025 $1,070,074,056 +$44,471,414 $45.93 359
2021 Q4 22,717,723 $1,389,309,843 -$126,515,786 $61.24 440
2021 Q3 23,366,967 $1,745,726,599 -$180,784,054 $74.72 459
2021 Q2 25,659,492 $2,370,135,079 +$42,779,459 $92.5 505
2021 Q1 25,148,571 $2,232,467,554 +$479,464,342 $88.73 498
2020 Q4 19,547,660 $1,827,150,655 +$624,694,863 $93.26 406
2020 Q3 11,839,290 $755,235,763 +$171,057,097 $63.71 235
2020 Q2 9,170,973 $478,909,682 +$200,541,364 $52.16 162
2020 Q1 5,396,249 $168,815,107 +$40,925,746 $31.28 96
2019 Q4 4,132,689 $138,545,355 +$25,605,525 $33.52 89
2019 Q3 3,368,985 $99,496,769 +$11,087,055 $29.52 77
2019 Q2 2,944,601 $101,482,198 +$13,071,418 $34.47 66
2019 Q1 2,580,644 $84,862,049 +$18,849,778 $32.88 61
2018 Q4 2,072,523 $50,378,685 +$43,577 $23.98 56
2018 Q3 1,939,768 $64,843,220 +$26,818,878 $33.43 56
2018 Q2 1,154,665 $33,528,825 +$11,399,069 $29.06 46
2018 Q1 771,773 $19,868,520 +$11,638,695 $25.75 39
2017 Q4 319,927 $7,861,613 +$1,291,433 $24.49 18
2017 Q3 264,822 $6,957,723 +$2,355,604 $26.24 12
2017 Q2 174,830 $3,913,000 +$3,191,214 $22.38 8
2017 Q1 33,397 $689,000 -$16,347 $20.69 4
2016 Q4 34,527 $586,000 +$32,517 $17.01 5
2016 Q3 32,597 $648,000 -$411,759 $19.89 5
2016 Q2 53,282 $897,000 +$82,555 $16.79 4
2016 Q1 48,349 $848,000 +$343,311 $17.54 5
2015 Q4 28,783 $603,000 +$219,908 $20.95 3
2015 Q3 18,282 $343,000 -$327,901 $18.76 1
2015 Q2 35,623 $821,000 +$190,002 $23.05 3
2015 Q1 27,374 $623,000 -$292,145 $22.69 2
2014 Q4 40,223 $854,000 +$801,000 $21.22 2